In clear cell renal cell carcinoma (ccRCC), high expression of FDX1 and DLAT predicts better survival; however, CDKN2A exhibits carcinogenic features, the overexpression of which is associated with worse survival in patients with ccRCC (Bian et al., 2022). This evidence concerns the gene DLAT and nonpapillary renal cell carcinoma.